0 CHECKOUT

PRODUCT FILTERS

REGION

720
392
389
364
364

COUNTRY

354
48
22
20
19

CATEGORIES

  • 262
  • 252
  • 197
  • 192
  • 183
  • 164
  • 147
  • 145
  • 143
  • 126
  • 117
  • 113
  • 60
  • 58
  • 40

PRICE

157
669
1,167
2,631

PUBLISHED

666
776
1,421
2,631

PRODUCT TYPE

2,512
113
3
2
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

Investigation Report on China's Megestrol Market, 2010-2019

Nowadays, breast cancer has the highest incidence among malignancy for women all over the world. According to statistics released by the World Health Organization (WHO), the number of breast cancer...

Published:  May 2015
Price:  From

Investigation Report on China's Megestrol Market, 2010-2019

Nowadays, breast cancer has the highest incidence among malignancy for women all over the world. According to statistics released by the World Health Organization (WHO), the number of breast cancer...

Published:  May 2015
Price:  From

Investigation Report on China's Trastuzumab Market, 2010-2019

Monoclonal antibody, an epochal drug variety, plays an important role in the upgrading process of treatments for tumor and autoimmune disease, and has become a mainstream in the global market of targeting...

Published:  June 2015
Price:  From

Global Lung Cancer Vaccine Market & Pipeline Insight 2015

Lung cancer incidences are rapidly increasing and various therapeutics have been introduced in global market to provide better care to patients. Surgery and radiation therapy are not preferred for lung...

Published:  February 2015
Price:  From

NDDS in Cancer Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

This study on novel drug delivery systems (NDDS) in cancer therapy comprises study of technologies such as embolization devices, liquid embolics and nanoparticles that offer unique approaches in cancer...

Published:  October 2014
Price:  From

Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2014

Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis....

Published:  July 2014
Price:  From

Companion Diagnostics in Personalized Medicine and Cancer Therapy

Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy. This linkage could be important in the therapeutic...

Published:  June 2014
Price:  From

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market – Pipeline Forecast & Market Forecast in G8 Countries (2011 – 2020)

The acute lymphocytic/lymphoblastic leukemia therapeutics market has growth potential with increasing incidence rate of the disease across the globe The incidence of acute lymphocytic/lymphoblastic...

Published:  December 2013
Price:  From

Global Multiple Myeloma Drugs Market 2015-2019

About Multiple Myeloma Multiple myeloma is a common cancer that affects the plasma cells, a type of white blood cell. It begins in the plasma cells of bone marrow. The primary function of the plasma...

Published:  December 2014
Price:  From

Global Non-small Cell Lung Cancer Market 2014-2018

About Non-small Cell Lung Cancer Non-small cell lung cancer occurs when normal cells grow and multiply without control after undergoing a cell transformation. Lung cancer is the leading cause of cancer...

Published:  September 2014
Price:  From

Thyroid Cancer: Disease and Pipeline Analysis

This report offers a unique therapeutic assessment and in-depth market and pipeline analysis, providing a view of the thyroid cancer market not available elsewhere. This report gives an overview of...

Published:  August 2014
Price:  From

Therapeutic Class Overview: Newer Oral Anti Androgens – Expanding Role in the Treatment Paradigm of Prostate Cancer

XTANDI (Enzalutamide) – Does it have potential to compete against ARN-509 in earlier setting? Zytiga (Abiraterone Acetate) – Ongoing Combination trials creates potential beyond Patent Expiry In recent...

Published:  February 2014
Price:  From

HPAPIs and Cytotoxic Drugs Manufacturing Market, 2014 - 2024

The ‘HPAPIs and Cytotoxic Drugs Manufacturing Market, 2014-2024’ report provides an extensive study of the rapidly growing manufacturing market of HPAPIs and cytotoxic drugs. Due to their numerous...

Published:  August 2014
Price:  From

Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018

About Non-Hodgkin Lymphoma (NHL) and its Diagnostic Procedures Non-Hodgkin lymphoma (NHL) is a condition of the human body leading to the production of abnormal lymphocytes. In normal circumstances,...

Published:  June 2014
Price:  From

Global Hodgkins Lymphoma Therapeutics Market 2014-2018

About Hodgkin's Lymphoma Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing...

Published:  August 2014
Price:  From

Global Cancer Monoclonal Antibodies Market & Pipeline Insight

Recent years have witnessed the emergence of monoclonal antibodies, which has the potential to offer less toxic and more efficient therapeutic alternatives for patients. Over the past decades, the researchers...

Published:  October 2014
Price:  From

Global Pancreatic Cancer Market 2014-2018

About Pancreatic Cancer Pancreatic cancer is a malignant cells form in the tissues of pancreas. Based on the initiation, pancreatic cancer can be classified into exocrine pancreatic cancer and endocrine...

Published:  October 2014
Price:  From

Global Non-Melanoma Skin Cancer Market 2014-2018

About Non-melanoma Skin Cancer Non-melanoma skin cancer is one of the most common types of cancer in the world It develops in the upper layers of the skin, but not in melanocytes There are two types...

Published:  May 2014
Price:  From

Bladder Cancer: Disease and Pipeline Analysis

This report offers an in-depth market and pipeline analysis of the bladder cancer market. This unique therapeutic assessment provides an overview of the current and future bladder cancer clinical development...

Published:  March 2014
Price:  From

Global Testicular Cancer Drugs Market 2014-2018

The analysts forecast the Global Testicular Cancer Drugs market to grow at a CAGR of 4 02 percent over the period 2013-2018 One of the key factors contributing to this market growth is the increasing...

Published:  January 2014
Price:  From
Loading Indicator

Our Clients